A Comparative Study of The Effectiveness of Glibenclamide vs. Glibenclamide with Metformin in Controlling Diabetes Mellitus in Patients Enrolled in The National Program for Treatment of Diabetes Mellitus Type 2 in Syria


Abstract in English

This study aims to compare between two globally approved strategies to manage diabetes type II in Syria, by comparing their effectiveness in patients with diabetes type II who are treated in the national program of diabetes Clinics in Damascus and investigate their glucose control. The first strategy includes glibenclamide as a monotherapy and the second includes a combination of glibenclamide and metformin.

References used

Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. Jan 2003;26 Suppl 1:S5-
Pittas A.pathophysiology of endocrinology,diabetes and metabolism.open course ware – tufts university.2005
Diagnosis and classification of diabetes mellitus. Diabetes Care. Jan 2010;33 Suppl 1:S67-24

Download